Nevertheless, during the follow-up, the use of beta-blockers was associated with significantly lower rates of mortality, when compared to those that did not receive this type of medication.
Sin embargo, durante el seguimiento el uso de los betabloqueantes se asoció a significativas menores tasas de mortalidad comparadas a aquellos que no recibieron estos medicamentos.